Yahoo Finance

OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies to Accelerate Production of Asymmetric siRNA for the Treatment of Sub-Retinal Fibrosis and Wet Macular ...

SUWON, Republic of Korea and LONDON, June 16, 2020 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (226950.KQ), a leading developer of RNAi therapeutics, today announced that the Company signed an ...
Yahoo Finance

OliX Pharmaceuticals to Present at 2021 ICR Conference

SUWON, Republic of Korea, Jan. 06, 2021 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company’s management will ...
Investing

OliX Pharmaceuticals Inc (226950)

OliX Pharmaceuticals Inc stock price live, this page displays KQ 226950 stock exchange data. View the 226950 premarket stock price ahead of the market session or assess the after hours quote. Monitor ...
Business Wire

OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1 Clinical Trial of Treatment of Androgenic Alopecia

SUWON, South Korea--(BUSINESS WIRE)--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today that it has received approval from the Human Research Ethics ...
Business Wire

OliX Pharmaceuticals Identifies Effective Inhibition of Target Gene Expression and Delivery of Candidate to Brain for CNS Therapeutics

SUWON, South Korea--(BUSINESS WIRE)--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company identified effective inhibition of target ...
PharmiWeb

OliX Pharmaceuticals Inks MOU with DynamiCure Biotechnology to Develop ADC Immunotherapy Using RNA at Korea-US Digital·BioHealth Business Forum

OliX participated in the ‘Korea-US Digital·BioHealth Business Forum’ hosted by the South Korean Ministry of Health and Welfare and Korea Health Industry Development Institute. The Company signed an ...
조선일보

OliX Pharmaceuticals announces joint obesity treatment development with Eli Lilly

OliX Pharmaceuticals, a bio company based on ribonucleic acid (RNA) interference technology, recorded the upper price limit following the market close on the 7th in after-hours transactions. This ...
Yahoo Finance

OliX Pharmaceuticals and PCI Biotech announce a collaboration to combine OliX asiRNA and PCI Biotech fimaNAc technologies

Suwon, South Korea and Oslo, Norway, May, 5 t h 2021 – OliX Pharmaceuticals Inc. (KOSDAQ: 226950) a leading developer of RNAi therapeutics, and PCI Biotech (OSE: PCIB), a cancer focused ...
BioWorld

Items Tagged with 'Olix Pharmaceuticals Inc.'

Dealmaking in the Asia Pacific (APAC) region took off this week, with the latest showcasing Genome & Co.’s licensing deal with Ellipses Pharma Ltd. for GENA-104, a phase I-ready immuno-oncology asset, ...
Investing

OliX Pharmaceuticals Inc (226950)

Find the OliX Pharmaceuticals financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the ...